SCHEMBL2803933

SCHEMBL2803933

Fc1ccccc1C1Cc2cnc(NCc3ccccc3)nc2-c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.57
FGFR2 P21802 2/20 0.57
CSF1R P07333 1/20 0.57
FGFR3 P22607 1/20 0.57
PTGS2 P35354 1/20 0.40
CCNA2 P20248 2/20 0.38
CDK2 P24941 2/20 0.38
CCNA1 P78396 2/20 0.38
AURKA O14965 1/20 0.38
MAPT P10636 2/20 0.37
TYRO3 Q06418 1/20 0.37
MERTK Q12866 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ATM Q13315 1/20 0.36
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805652 0.91 FGFR1 (0.56) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2807057 0.90 FGFR1 (0.62) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2806866 0.90 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3TYRO3
SCHEMBL2805361 0.89 FGFR1 (0.56) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2804389 0.87 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3PTGS2
SCHEMBL2804043 0.87 FGFR1 (0.47) FGFR1FGFR2CSF1RFGFR3PTGS2
SCHEMBL2805010 0.86 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2802702 0.86 FGFR1 (0.52) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2804864 0.85 FGFR1 (0.57) FGFR1FGFR2CSF1RFGFR3GAA
SCHEMBL2803196 0.85 FGFR1 (0.50) FGFR1FGFR2CSF1RFGFR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.